We are delighted to announce the winner of this Cardio-Oncology manuscript competition, which has been sponsored by ICOS in collaboration with the Thalheimer Center for Cardio-Oncology at the University of Pennsylvania.
Congratulations to Drs. Prince Otchere, Olusola Adekoya, Samuel B. Governor, Naveen Vuppuluri, Akruti Prabhakar, Stella Pak, Oduro Oppong-Nkrumah, Francis Cook, Rudy Bohinc, and Gregory Aune for their winning paper: Development of cardiac risk prediction model in patients with HER-2 positive breast cancer on trastuzumab therapy.
The judges selected the article based on originality and impact and noted: “This report has broad potential applicability as it provides clinically relevant information on the value of cardiac echo monitoring in omen with early stage HER2+ breast cancer who have different risks for treatment-related cardiotoxicity. The identified risks factors for developing treatment emergent cardiotoxicity are universally available for all breast cancer patients. The high negative predicative value at 94% facilitates clinical decision-making in patients who lack risk factors although Level I guideline recommendations for increasing the recommended intervals between echoes require prospective evaluation of outcomes of different imaging strategies. The authors note the limitations of their findings and the opportunities for future research based on their findings.”
Their prize, awarded to first author Dr. Prince Otchere, includes:
- a fully waived APC on a second Cardio-Oncology manuscript within one year (the journal's standard peer review process would apply);
- ICOS dues paid for one year;
- free registration at GCOS 2023;
- and prominent promotion of the winning article by ICOS and the journal.
Please see below to read all articles accepted for publication as part of this competition.